194 related articles for article (PubMed ID: 23034593)
21. The Foot-and-Mouth Disease Carrier State Divergence in Cattle.
Stenfeldt C; Eschbaumer M; Rekant SI; Pacheco JM; Smoliga GR; Hartwig EJ; Rodriguez LL; Arzt J
J Virol; 2016 Jul; 90(14):6344-64. PubMed ID: 27147736
[TBL] [Abstract][Full Text] [Related]
22. Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles.
Pan L; Zhang Z; Lv J; Zhou P; Hu W; Fang Y; Chen H; Liu X; Shao J; Zhao F; Ding Y; Lin T; Chang H; Zhang J; Zhang Y; Wang Y
Int J Nanomedicine; 2014; 9():5603-18. PubMed ID: 25506214
[TBL] [Abstract][Full Text] [Related]
23. Systemic immune response and virus persistence after foot-and-mouth disease virus infection of naïve cattle and cattle vaccinated with a homologous adenovirus-vectored vaccine.
Eschbaumer M; Stenfeldt C; Rekant SI; Pacheco JM; Hartwig EJ; Smoliga GR; Kenney MA; Golde WT; Rodriguez LL; Arzt J
BMC Vet Res; 2016 Sep; 12():205. PubMed ID: 27634113
[TBL] [Abstract][Full Text] [Related]
24. Kinetics of immune response to foot-and-mouth disease virus (type Asia 1) in experimental cattle.
Maddur MS; Gajendragad MR; Kishore S; Gopalakrishna S; Singh N
Vet Res Commun; 2009 Feb; 33(2):103-9. PubMed ID: 18648998
[TBL] [Abstract][Full Text] [Related]
25. Induction of an antigen-specific immune response and partial protection of cattle against challenge infection with foot-and-mouth disease virus (FMDV) after lipopeptide vaccination with FMDV-specific B-cell epitopes.
Höhlich BJ; Wiesmüller KH; Haas B; Gerner W; Correa R; Hehnen HR; Schlapp T; Pfaff E; Saalmüller A
J Gen Virol; 2003 Dec; 84(Pt 12):3315-3324. PubMed ID: 14645912
[TBL] [Abstract][Full Text] [Related]
26. Comparison of immune responses after intra-typic heterologous and homologous vaccination against foot-and-mouth disease virus infection in pigs.
Eblé PL; de Bruin MG; Bouma A; van Hemert-Kluitenberg F; Dekker A
Vaccine; 2006 Feb; 24(9):1274-81. PubMed ID: 16289709
[TBL] [Abstract][Full Text] [Related]
27. Differential antibody responses to the major antigenic sites of FMD virus serotype O after primo-vaccination, multiply-vaccination and after natural exposure.
Biswal JK; Subramaniam S; Ranjan R; VanderWaal K; Sanyal A; Pattnaik B; Singh RK
Infect Genet Evol; 2020 Mar; 78():104105. PubMed ID: 31706082
[TBL] [Abstract][Full Text] [Related]
28. A Vaccine Based on the A/ASIA/G-VII Lineage of Foot-and-Mouth Disease Virus Offers Low Levels of Protection against Circulating Viruses from the A/ASIA/Iran-05 lineage.
Singanallur NB; Eblé PL; Ludi AB; Statham B; Bin-Tarif A; King DP; Dekker A; Vosloo W
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062300
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of cross-protection between O1 Manisa and O1 Campos in cattle vaccinated with foot-and-mouth disease virus vaccine incorporating different payloads of inactivated O1 Manisa antigen.
Nagendrakumar SB; Srinivasan VA; Madhanmohan M; Yuvaraj S; Parida S; Di Nardo A; Horsington J; Paton DJ
Vaccine; 2011 Feb; 29(10):1906-12. PubMed ID: 21236232
[TBL] [Abstract][Full Text] [Related]
30. [Evaluation of synthetic peptide vaccines against foot-and-mouth disease type A].
Tang H; Liu X; Fang Y; Jiang S; Pan L; Lv J; Zhang Z; Zhou P; Zhang Y; Wang Y
Wei Sheng Wu Xue Bao; 2013 Jun; 53(6):596-607. PubMed ID: 24028062
[TBL] [Abstract][Full Text] [Related]
31. Early antibody responses of cattle for foot-and-mouth disease quadrivalent double oil emulsion vaccine.
Patil PK; Bayry J; Nair SP; Gopalakrishna S; Sajjanar CM; Misra LD; Natarajan C
Vet Microbiol; 2002 Jun; 87(2):103-9. PubMed ID: 12034538
[TBL] [Abstract][Full Text] [Related]
32. Immunity of foot-and-mouth disease serotype Asia 1 by sublingual vaccination.
Chen HT; Liu YS
PLoS One; 2013; 8(5):e63839. PubMed ID: 23717497
[TBL] [Abstract][Full Text] [Related]
33. Systemic Foot-and-Mouth Disease Vaccination in Cattle Promotes Specific Antibody-Secreting Cells at the Respiratory Tract and Triggers Local Anamnestic Responses upon Aerosol Infection.
Pega J; Di Giacomo S; Bucafusco D; Schammas JM; Malacari D; Barrionuevo F; Capozzo AV; Rodríguez LL; Borca MV; Pérez-Filgueira M
J Virol; 2015 Sep; 89(18):9581-90. PubMed ID: 26157128
[TBL] [Abstract][Full Text] [Related]
34. A synthetic peptide containing the consensus sequence of the G-H loop region of foot-and-mouth disease virus type-O VP1 and a promiscuous T-helper epitope induces peptide-specific antibodies but fails to protect cattle against viral challenge.
Rodriguez LL; Barrera J; Kramer E; Lubroth J; Brown F; Golde WT
Vaccine; 2003 Sep; 21(25-26):3751-6. PubMed ID: 12922108
[TBL] [Abstract][Full Text] [Related]
35. Serological responses of cattle inoculated with inactivated trivalent foot-and-mouth disease vaccine at the wildlife-livestock interface of the Kruger National Park, South Africa.
Lazarus DD; van Schalkwyk OL; Burroughs REJ; Mpehle A; Reininghaus B; Rikhotso O; Heath L; Maree FF; Blignaut B; Fosgate GT
Prev Vet Med; 2018 Oct; 158():89-96. PubMed ID: 30220400
[TBL] [Abstract][Full Text] [Related]
36. Association of the expression of Th cytokines with peripheral CD4 and CD8 lymphocyte subsets after vaccination with FMD vaccine in Holstein young sires.
Yang L; Liu Z; Li J; He K; Kong L; Guo R; Liu W; Gao Y; Zhong J
Res Vet Sci; 2018 Aug; 119():79-84. PubMed ID: 29885549
[TBL] [Abstract][Full Text] [Related]
37. Combination of Adt-O1Manisa and Ad5-boIFNλ3 induces early protective immunity against foot-and-mouth disease in cattle.
Diaz-San Segundo F; Montiel NA; Sturza DF; Perez-Martin E; Hickman D; Ramirez-Medina E; Grubman MJ; de Los Santos T
Virology; 2016 Dec; 499():340-349. PubMed ID: 27743960
[TBL] [Abstract][Full Text] [Related]
38. Engineering foot-and-mouth disease viruses with improved growth properties for vaccine development.
Zheng H; Guo J; Jin Y; Yang F; He J; Lv L; Zhang K; Wu Q; Liu X; Cai X
PLoS One; 2013; 8(1):e55228. PubMed ID: 23372840
[TBL] [Abstract][Full Text] [Related]
39. Proliferative lymphocyte responses to foot-and-mouth disease virus and three FMDV peptides after vaccination or immunization with these peptides in cattle.
van Lierop MJ; van Maanen K; Meloen RH; Rutten VP; de Jong MA; Hensen EJ
Immunology; 1992 Mar; 75(3):406-13. PubMed ID: 1349300
[TBL] [Abstract][Full Text] [Related]
40. Development of foot-and-mouth disease virus (FMDV) serotype O virus-like-particles (VLPs) vaccine and evaluation of its potency.
Mohana Subramanian B; Madhanmohan M; Sriraman R; Chandrasekhar Reddy RV; Yuvaraj S; Manikumar K; Rajalakshmi S; Nagendrakumar SB; Rana SK; Srinivasan VA
Antiviral Res; 2012 Dec; 96(3):288-95. PubMed ID: 23043941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
